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Abstract
Introduction: Diagnosis of infections due to Mycobacterium tuberculosis has
been recently facilitated with the worldwide implementation of rapid molecular
tests. However, the diagnosis of non-TB mycobacteria (NTM) remains a major
challenge for laboratories, as this group of bacteria contains over 150 different
species with highly variable bacteriological properties. The development and
implementation in clinical practice of techniques allowing rapid identification of
NTM at the species level is, therefore, important for clinical laboratories. We report
the case of an HIV-1 positive patient presenting with severe NTM infection who
benefited from a novel rapid diagnostic technique, based on the direct sequencing
of the rpoB gene from smear-positive clinical samples. Case Presentation: A 43-
year-old HIV-1 positive woman was hospitalized for bicytopenia in the presence
of an inflamed supraclavicular lymph node. The diagnosis of disseminated
Mycobacterium genavense infection, which involv...
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Introduction: Diagnosis of infections due to Mycobacterium tuberculosis has been recently
facilitated with the worldwide implementation of rapid molecular tests. However, the diagnosis
of non-TB mycobacteria (NTM) remains a major challenge for laboratories, as this group of
bacteria contains over 150 different species with highly variable bacteriological properties. The
development and implementation in clinical practice of techniques allowing rapid identification
of NTM at the species level is, therefore, important for clinical laboratories. We report the case
of an HIV-1 positive patient presenting with severe NTM infection who benefited from a novel
rapid diagnostic technique, based on the direct sequencing of the rpoB gene from
smear-positive clinical samples.
Case Presentation: A 43-year-old HIV-1 positive woman was hospitalized for bicytopenia in
the presence of an inflamed supraclavicular lymph node. The diagnosis of disseminated
Mycobacterium genavense infection, which involved the bone marrow and several lymph nodes,
was missed by conventional mycobacteriological techniques. Identification was obtained by
performing direct sequencing of the rpoB gene.
Conclusion: We describe a novel technique that allows the rapid diagnosis of NTM infections
directly from biological samples. This technique is now implemented in our routine workflow for
smear and culture-positive samples, after the exclusion of TB, by rapid molecular assays.
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Introduction
The diagnosis of infections due toMycobacterium tuberculosis
(Mtb) has made an unprecedented step forward recently with
the worldwide implementation of rapid molecular tests.
However, the diagnosis of non-TB mycobacteria (NTM)
remains a major challenge for laboratories, as this group of
bacteria contains over 150 different species presenting with
variable bacteriological properties and clinical significance.
Current molecular techniques lack sensitivity and are unable
to distinguish mycobacterial species or subspecies to a level
that would guide therapeutic management. Development of
techniques allowing rapid identification of NTM at the species
level is, therefore, important for clinical laboratories.
†These authors contributed equally to this paper.
Abbreviations: ART, antiretroviral therapy; FDG PET CT, fluorodeoxy-
glucose positron emission tomography computed tomography; HIV,
human immunodeficiency virus; IRIS, immune reconstitution inflammatory
syndrome; Mtb, Mycobacterium tuberculosis; NTM, non-TB mycobacteria;
TB, tuberculosis; VL, plasma viral load.
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We report the case of a patient presenting with dissemi-
nated infection due to Mycobacterium genavense, a rare
and hardly cultivable mycobacterial species. The patient
benefited from direct sequencing of the bacterial rpoB
gene from smear-positive clinical samples.
Case Report
Here, we describe the case of a 43-year-old woman, hospi-
talized for bicytopenia, in the presence of an inflamed
supraclavicular lymph node.
The patient was diagnosed with human immunodeficiency
virus-1 (HIV-1) infection nine years previously and had
been treated with antiretroviral therapy (ART) containing
abacavir/lamivudine and nevirapine for the past six years.
She was then lost to follow up for three years and ART
was interrupted.
The patientwas admitted forPneumocystis jirovecipneumonia.
Her CD4 cell count was 4 ml21 with a plasma viral load (VL) of
273.423 copies ml21. Antiretroviral therapy containing teno-
fovir/emtricitabine and dolutegravir was begun.
Two months later, she was readmitted for fever, chills and
night sweats. Clinical examination revealed an inflamed
supraclavicular lymphadenopathy. The CD4 cell count
was 66 cells ml21, and VL was 144 copies ml21. Further
blood tests revealed anaemia (Hb: 10.8 g l21) a low white
blood cell count (3030 leukocytes ml21) and C-reactive
Protein at 56 mg l21 (Nl value: v5 mg l21).
A bone marrow aspirate was performed to exclude a hae-
matological neoplasm. Cytological examination showed
more than 60 % reactive plasmocytes locally, rare
epithelioid granulomas and a single Langhans giant cell
with no clear cell border (Fig. 1).
An 18F-fluorodeoxyglucose positron emission tomography-
computed tomography scan (FDG PET-CT scan) was
performed and showed abnormal metabolic activity in
the spleen, and in multiple lymph nodes located in the
cervical, mediastinal, hepatic, periaortic and iliac regions
(Fig. 2).
A biopsy of the supraclavicular lymph node was per-
formed. Direct smears showed over 100 acidfast bacilli
per microscopic field, as illustrated in Fig. 3. A TB-specific
PCR (GeneXpert MTB/RIF, Cepheid) performed on the
same day gave a negative result for the Mtb complex.
Despite these early microbiological results, anti-TB treat-
ment composed of rifabutin (300 mg day21), isoniazid
(300 mg day21), ethambutol (800 mg day21) and pyrazi-
namide (1000 mg day21) began rapidly. Rifabutin was pre-
ferred to rifampicin to avoid drug-drug interactions with
dolutegravir (Miller et al., 2015). Five days later, the
patient developed a biological hepatitis with liver enzymes
five times over the upper normal limit. Pyrazinamide and
isoniazid were stopped and liver function improved
rapidly.
In the meantime, additional bacteriological investigations
were performed. DNA was extracted from the lymph
node using a commercial Fluorolyse kit (Hain Lifescience).
The DNA strip assay, GenoType Mycobacterium CM
(Hain Lifescience), confirmed the presence of the genus
Mycobacterium, but did not provide a species identifi-
cation. We performed DNA sequencing of the rpoB gene
as described below.
Fig. 1. Bone marrow. May–Gru¨nwald Giemsa staining showing: (A) non-necrotizing epithelioid granuloma composed of
epithelioid histiocytes surrounded by small lymphocytes (ly) and reactive plasmocytes (pl); (B) a multinucleated giant
Langhans cell (La). Bars, 20 mm.
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As a first step, PCR amplification of the rpoB gene was
carried out using the KOD Hot start master mix (Merck
Millipore) with the primers, My9 and MycoR. These
primers amplify a 800 bp region, presenting significant
variations between mycobacterial species. Amplicons were
purified with a QIAquick PCR purification kit (Qiagen)
and diluted to 10 ng ml21.
The second sequencing step was performed on an ABI 3130
system (Life Technologies) using a BigDye Terminator v3.1
Cycle Sequencing and BigDye XTerminator Purification kit
(Applied Biosystems, ref. 4376486) with primers My10,
My11 and MycoF (Table 1).
A sequence of 643 bp was obtained, for which analysis was
performed using a Smartgene Bacteria module (Smart-
gene), which had 100 % homology with Mycobacterium
genavense (accession number HM022216).
This technique was applied to fresh samples and to samples
which had been fixed in paraffin.
Based on these results, clarithromycin (500 mg b.i.d.) was
added rapidly to the treatment as recommended in the
ATS/IDSA guidelines (Griffith et al., 2007) with good clini-
cal evolution after one month.
Bone marrow and lymph node samples were cultured in an
MGIT 960 instrument at 37 uC for ten weeks and in
Lowenstein-Jenssen media incubated at 30 uC, 35 uC and
42 uC for eight weeks. All these media remained sterile.
Discussion
Immune reconstitution inflammatory syndrome (IRIS) is a
common complication of ART initiation among HIV
patients, particularly in those with an advanced state of
immunosuppression (CD4 count v50 ml21). It typically
occurs as CD4 cell numbers increase and it is linked to
the paradoxical worsening of pre-existing subclinical
opportunistic infections due to pathogens such as TB
and NTM, Cryptococci and Cytomegalovirus (Barber et al.,
2014; DeSimone et al., 2000; French, 2012; Griffith et al.,
Fig. 2. FDG PET-CT scans indicating (areas circled in blue): (A) the supra-clavicular lymph node; (B) and (C) multiple
hypermetabolic lymph nodes in the hepatic, periaortic and iliac regions. Note the high metabolic activity of the spleen =.
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2007; Walker et al., 2015,). IRIS can be severe and require
the rapid initiation of an effective treatment.
Although Mtb remains the most prevalent species, in our
particular experience (low incidence of TB), NTM represent
an emerging problem (up to 50 % ofMycobacteria identified
in the lab are non-TB species). NTM can be particularly
severe among immunosuppressed patients, requiring a
rapid diagnosis and rapid initiation of treatment (Murthy
et al., 2015; van der Werf et al., 2014). In the clinical case
presented above, rapid identification of a species of NTM
directly from a clinical sample permitted the definite
exclusion of Mtb infection and the initiation of a treatment
oriented towards Mycobacterium genavense.
Mycobacterium genavense is a clinically relevant pathogen
among immunocompromised patients, causing dissemi-
nated disease with serious morbidity and mortality
(Santos et al., 2014). The prevalence of these infections
may be underestimated due to the difficulties in recovering
the bacteria from the usual culture media, such as MGIT
and LJ, used in clinical practice (Thomsen et al., 1999).
Reports suggest that Mycobacterium genavense may grow
on these media after up to 90 days of incubation at 45 uC
in liquid media with an acid pH and Mycobactin J as a
supplement. These specific requirements are not imple-
mentable in routine practice.
Rapid and accurate diagnostic methods for this growing
group of opportunistic pathogens should, therefore, be
made widely accessible. Using the technique described
above, we were able to perform rapid species identification
directly from smear-positive clinical specimens.
This technique has since been implemented in our routine
workflow for smear-positive samples with negative Mtb PCR.
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Fig. 3. Cervical lymph node. (A) May–Gru¨nwald Giemsa staining showing poorly cohesive lymphocytes (Ly), reactive plas-
mocytes (Pl) and irregularly stained mycobacteria (Ba). (B) Ziehl–Neelsen staining showing numerous acid-fast bacilli (Ba)
coloured in pink. Bars, 20 mm.
Table 1. Primers used for the amplification of the rpob ‘identification’ region based on the Mtb H37Rv sequence (accession num-
ber AL123456.3)
Primer Forward or reverse Sequence (59- 39) Location Source
My 9 F ATCGGCGCCGAGGTCCGCGAC 2356–2376 This paper
My 10 F AAGGTGCCSCACGGTGAGTC 2494–2517 This paper
My 11 R ATGTAGCCGACCGTSACCGGGT 3044–3065 This paper
MycoF F GGCAAGGTCACCCCGAAGGG 2392–2411 (Ade´kambi et al., 2003)
MycoR R AGCGGCTGCTGGGTGATCATC 3135–3152 (Ade´kambi et al., 2003)
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